Breast cancer confessions: The emotional work of disclosing a diagnosisAugust 04, 2008Sociological research examines how women relate their breast cancer diagnosis to loved ones; concludes that disclosure is 'work' BOSTON - Women diagnosed with breast cancer shoulder the emotional burden of disclosing their diagnosis to loved ones, managing the feelings of others at precisely the time when they need support themselves, according to research to be presented at the annual meeting of the American Sociological Association (ASA). The research is the first study to comparatively and qualitatively examine how breast cancer survivors from different racial and ethnic backgrounds share the news of their illness with family, friends and acquaintances. The researchers interviewed 164 breast cancer survivors to examine the "emotion work" involved in disclosing a breast cancer diagnosis. These survivors included a mix of racially diverse women born in the United States and immigrants, and they were recruited throughout the San Francisco Bay area. "Women diagnosed with breast cancer face an uphill emotional battle," said Grace J. Yoo, a sociologist at San Francisco State University and the study's primary investigator. "At a time when they are forced to deal with their own vulnerabilities, women with breast cancer must also navigate the vulnerabilities of loved ones as they react to the news." For women-typically perceived as caregivers and expected to put the emotions of others above their own-a breast cancer diagnosis presents a paradox, according to Yoo. Women must face the challenge of determining how to ask for help from others when they are typically seen as the caregiver. According to interviews with breast cancer survivors, different strategies were employed in conversations with close family members compared to those outside the family. Survivors viewed informing their family of the diagnosis as their most difficult task following a diagnosis. Most respondents felt the need to strategically manage the way family members were told in order to protect their loved ones and to provide comfort and reassurance. Contrary to the approach they used with their families, women often related their diagnosis to peers spontaneously. Most respondents were surprised by the extent of the support they received as a result of these unplanned conversations and by the depth and breadth of their own social networks. "Women who limit their emotions in discussing their breast cancer diagnosis often limit the possibilities for support they can receive," said Yoo. "Involving and including others in an illness increases intimacy among friends and family and opens the door to additional support." Yoo co-authored the study with researchers Caryn Aviv from the University of Denver; Ellen G. Levine of San Francisco State University; and Cheryl Ewing and Alfred Au, both of the UCSF Comprehensive Cancer Center. American Sociological Association |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||